The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
April 22nd 2024
Prolonged modified fasting, in a multimodal medical approach, may help patients with fibromyalgia improve pain and psychosomatic symptoms.
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 2024
Register Now!
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Optimal Approaches to Recognizing and Treating ANCA-Associated Vasculitis
View More
Medical Specialists Mount International Effort to Restore Critical Epilepsy Services in Haiti
The international community of epilepsy specialists is providing financial support and specialized medical equipment contributed by its manufacturer to help re-establish services to epilepsy patients in Haiti halted by the devastating earthquake.
Medical Marijuana: Smoke & Mirrors?
February 2nd 2010When our home state of New Jersey became the 14th state in the nation to legalize medical marijuana, OBTN decided to take a closer look at the herbal remedy. With help from oncologists on our advisory board, we sought to filter through the smoke and examine the realities of medical marijuana.
Osteoarthritis treatment update: Are NSAIDs still in the picture?
February 1st 2010Although NSAIDs are the most effective treatment for persons who experience the pain of osteoarthritis (OA), the risk of adverse effects with NSAIDs may outweigh the benefits in many older patients. The GI risk is well known; increased attention has been paid recently to the cardiovascular risk. The goals of OA management are pain reduction and improvement or preservation of mobility. A multidisciplinary approach to treatment is recommended.
Biomarker Could Help Doctors Tailor Treatment for Rheumatoid Arthritis
January 29th 2010TNF antagonists are not highly effective in 30 to 50 percent of patients, but investigators have discovered that patients with higher baseline levels of type I interferon beta were more likely to respond to therapy.